MaxCyte MXCT Q1 2026 Earnings EPS Surprises Positively on LowerThanExpected Loss Revenue Not Disclosed ASMB Q1 2026 Earnings Narrowed Loss and Pipeline Progress Boost Investor Sentiment Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress Adial Pharmaceuticals ADIL Q1 2026 Earnings NarrowerThanExpected Loss as Operational Progress Continues RILYT Q1 2024 Earnings Net Loss Reported as Holding Company Faces Challenges Notes Rise 11 Magna International MGA Q1 2026 Earnings Strong EPS Beat Drives Stock Higher